We must invest in more than vaccines because vaccines represent only one tool in a much larger public health system—and that system is failing. A vaccine can prevent disease, but it cannot detect emerging threats early, diagnose complicated conditions in underserved areas, or reach the communities that need it most. This matters profoundly for brain health: dementia diagnosis, Parkinson’s detection, and stroke prevention all depend on regional lab capacity, trained specialists, and data systems that can identify patterns before disease becomes critical. When the infrastructure crumbles, even the best vaccines cannot close the gap. The gap is real and widening. While the global vaccine market is projected to grow from $97.97 billion in 2026 to $170.60 billion by 2035, and individual vaccines deliver impressive returns—every dollar invested in immunization in the world’s poorest countries returns $16 to $44—this success masks a deeper crisis.
Public health agencies in the United States lack the foundational capacity to do the work that must happen between vaccine campaigns: they cannot reliably detect new disease variants, modernize their lab networks, or maintain the trained workforce that keeps communities safe. Consider what happened during COVID. The vaccine program worked; it paid for itself within one year through reduced hospitalizations and deaths. But adequate laboratory sequencing capacity did not exist. Many healthcare facilities could not identify which variant they were seeing, and surveillance networks that should have been detecting new threats in real time were overwhelmed, understaffed, and using paper records. A vaccine alone cannot solve that problem.
Table of Contents
- Why Vaccine Success Hides Infrastructure Failure
- The Public Health Workforce Is Shrinking and Aging
- The Three Pillars of Infrastructure That Vaccines Cannot Build
- Rural Communities Face the Steepest Infrastructure Gaps
- The Proposed Budget Cuts Undermine Everything
- Why the Job Market Mismatch Matters for Service Capacity
- The Infrastructure Requirement for Early Detection of Cognitive Decline
Why Vaccine Success Hides Infrastructure Failure
Vaccines are one of medicine’s greatest achievements. The science is proven, the return on investment is undeniable, and the political consensus around vaccination programs has deep roots. But this success has created a dangerous blind spot: the assumption that vaccine funding and vaccine capacity equal public health capacity. They do not. Modernizing the nation’s public health information systems and infrastructure requires a minimum of $8 billion per year for 10 years—a staggering sum, but essential. As of December 2025, the CDC’s Public Health Infrastructure Grant has awarded over $5 billion to health departments across all 50 states, Washington D.C., territories, and large localities. This sounds substantial, but it falls short of the need.
To put this in perspective: the U.S. is committing roughly $5 billion total to a problem that costs $8 billion annually to solve. At current funding, the nation would need to maintain this investment for 16 years just to address a single decade’s worth of infrastructure gaps. The real limitation is not scientific; it is political and financial. Vaccines work because they are discrete, time-limited interventions that produce measurable results. Infrastructure—lab networks, data systems, surveillance capacity, workforce training—is invisible to voters until it fails catastrophically. This creates a funding gap that no amount of vaccine success can bridge.
The Public Health Workforce Is Shrinking and Aging
Behind every functional public health system is a trained workforce. The emergency preparedness workforce comprises roughly 13 percent of the state and local public health workforce—approximately 30,000 workers responsible for detecting outbreaks, coordinating responses, and maintaining readiness for the next crisis. These workers are not being replaced. Of preparedness health workers, 23 percent are age 35 or younger and 28 percent are 55 or older, indicating significant turnover risk in the next five to ten years. Nearly half—49 percent—of preparedness staff have been with their agency for less than five years, which means institutional knowledge is fragmentary.
When experienced epidemiologists, lab directors, and outbreak coordinators retire, they often leave without a trained successor. The pipeline does not exist to refill these roles at the scale needed. This matters for dementia and neurological disease detection in ways that are not immediately obvious. Early identification of Parkinson’s disease, Alzheimer’s disease, and stroke risk depends on primary care networks that are supported by strong public health surveillance, regional labs that can process biomarkers, and data systems that can identify clusters of disease in a community. Without a trained workforce to staff these systems, detection delays by months or years. By the time a diagnosis is confirmed, preventable or modifiable risk windows have closed.
The Three Pillars of Infrastructure That Vaccines Cannot Build
The CDC’s Public Health Infrastructure Grant focuses on three foundational pillars: skilled workforce recruitment, retention, and training; data modernization; and foundational public health capabilities. At least 40 percent of state funding flows directly to local health departments, which are the frontline of any detection system. Data modernization deserves particular attention because it is unsexy and therefore chronically underfunded. Modern public health depends on real-time data integration: connecting clinical labs, hospital discharge data, pharmacy records, and field reports into a coherent picture of disease patterns in a region. Many U.S.
health departments still operate on fragmented systems, some still using paper forms, others using disconnected databases from the 1990s. Upgrading this infrastructure is neither quick nor cheap, but it is the difference between detecting a disease cluster in weeks versus missing it for a year. A comparison illustrates the point. During a recent measles outbreak in a mid-sized metropolitan area, one health department with a modern data system identified the outbreak, traced contacts, and coordinated vaccination outreach within two weeks. A neighboring county with outdated systems did not recognize the pattern until six weeks later, after cases had spread significantly. No vaccine rollout could have prevented that delay; only infrastructure prevented it.
Rural Communities Face the Steepest Infrastructure Gaps
Rural America faces a compounded crisis. Rural health departments are smaller, have less technical capacity, and must cover larger geographic areas with fewer resources. The Rural Health Transformation Program, launched in 2025, dedicates $50 billion over five years to improve rural health infrastructure nationally. This is essential but also reveals the baseline: rural health is in such poor condition that it requires a $50 billion intervention to bring it toward adequacy. In rural areas, public health surveillance often depends on a single state epidemiologist or a part-time county health officer who manages vaccination records, disease reporting, outbreak response, and environmental health compliance simultaneously.
They cannot attend training, they cannot mentor junior staff, and when they leave, the position sits vacant for months because the pay is low and the burden is unsustainable. No vaccine campaign can overcome this structural disadvantage. For residents of rural areas concerned about dementia risk or seeking early neurological screening, the consequences are direct. Rural hospitals may lack the specialists, imaging capacity, or lab capability to diagnose cognitive impairment early. A patient in a rural county may be diagnosed with dementia years after a patient in an urban center, simply because the infrastructure to screen for cognitive decline does not exist.
The Proposed Budget Cuts Undermine Everything
In his proposed FY 2026 budget, the President requested a 53 percent reduction in CDC funding compared to FY 2024. To frame this: after years of inadequate investment in public health infrastructure, the nation is now proposed to cut the funding that is just beginning to address that backlog. This is not a course correction; it is abandonment.
The timing is particularly dangerous because the infrastructure grant awards are still flowing to states and localities. Many regions are in the early stages of modernizing their data systems, hiring and training epidemiologists, and establishing lab capacity. A sharp funding cut would halt these projects mid-implementation, leaving communities with partially modernized systems that cannot function. The cost of restarting these efforts later will exceed the cost of completing them now.
Why the Job Market Mismatch Matters for Service Capacity
Despite the bleak workforce picture, Altarum forecasts that ambulatory healthcare services will create roughly 1.2 million new public health jobs by 2034. On the surface, this seems promising—a large and growing sector. But the mismatch is critical: most of these jobs are in clinical care, not in the public health workforce that conducts surveillance, manages disease investigation, and maintains preparedness capacity.
A nurse practitioner opening in a rural clinic is a good thing, but it does not train an epidemiologist to detect an emerging threat, and it does not strengthen the lab network that confirms disease cases. The job growth is happening in the wrong sector relative to the infrastructure need. Without targeted recruitment and training programs that direct talent toward public health agencies rather than clinical care, the workforce gap will deepen even as the healthcare industry expands overall.
The Infrastructure Requirement for Early Detection of Cognitive Decline
This article has focused on vaccines and general public health readiness, but the connection to dementia and brain health is direct. Early detection of cognitive decline, identification of Parkinson’s disease, and prevention of stroke-related cognitive loss all depend on infrastructure elements that have nothing to do with vaccines. Cognitive screening requires trained primary care clinicians, access to cognitive testing or biomarker analysis, and—critically—systems for ensuring that results reach specialists for timely diagnosis and intervention.
Many health departments have abandoned cognitive health surveillance entirely because they lack the capacity. No vaccine will solve this; only investment in clinical data systems, training of healthcare workers in cognitive screening protocols, and regional lab capacity for advanced biomarker testing will suffice. The choice between vaccines and infrastructure is not a real choice. Both are necessary, and infrastructure is being starved.
- —
